Is Exact Sciences Corporation Stock a Buy?
Owning a stock that doubles in value in less than 11 months is exciting. But what word do you use for a stock that rises to 4.5 times its original price in that amount of time? Thrilling? Exhilarating? Whatever word is the best fit, it applies to Exact Sciences (NASDAQ: EXAS).
Everything that could go right seems to be doing so for the company behind the popular Cologuard DNA screening test for colorectal cancer. But with its rapid rise leading to a very lofty valuation, is Exact Sciences stock still one for investors to buy?
Image source: Getty Images.
Source: Fool.com
Exact Sciences Stock
€39.06
-0.700%
With 15 Buy predictions and not the single Sell prediction the community is currently very high on Exact Sciences.
With a target price of 80 € there is potential for a 104.81% increase which would mean more than doubling the current price of 39.06 € for Exact Sciences.
